Skip to main content
SpringerLink
Log in

Longitudinal study of soluble intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves’ disease

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Adhesion molecules, such as Intercellular Adhesion Molecule-1 (ICAM-1), play an important role during the autoimmune process of Graves’ disease (GD). So the objective of the study was to evaluate the time-course of the soluble ICAM-1 (sICAM-1) in GD. Concentrations of sICAM-1, thyroid hormones and TSAb (thyroid-stimulating antibodies) were determined in sera from 30 healthy controls, 41 untreated GD patients and after 3, 6, 12, 18 months of carbimazole therapy (no.=30), at relapse (no.=11) or 2 years after the end of therapy when remission (no.=13). Mean sICAM-1 concentration was significantly higher in untreated GD patients than in controls (mean±SD: 371±108 ng/ml vs 243±47 ng/ml, p<0.0001) until 6 months of therapy (289±102 ng/ml; NS). The number of positive patients (sICAM-1 levels>mean of the controls+ 2 SD) declined from 56% (23/41) at the time of the diagnosis to 10% (3/29) at 18 months. At relapse, mean sICAM-1 level significantly increased compared to that at 18 months of therapy (288±65 vs 236±59 ng/ml, p=0.005). At remission mean sICAM-1 level was significantly lower than in relapse patients (240±48 ng/ml, p=0.04); no patient displayed sICAM-1 positive values. In conclusion, sICAM-1 concentrations were increased in sera of newly diagnosed GD patients, declined significantly during carbimazole therapy and could again be increased at relapse. sICAM-1 could reflect an ongoing immune process and help to affirm the presence of an autoimmunity notably in some cases of TSAb negative patients. However its precise interest in clinical practice remains to be determined in further studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

References

  1. Pozzilli P., Carotenuto P., Delitala G. Lymphocytic traffic and homing into target tissue and the generation of endocrine autoimmunity. Clin. Endocrinol. 1994 (Oxf.) 41: 545–554.

    Article  CAS  Google Scholar 

  2. Springer T.A. Adhesion of the immune system. Nature 1990, 346: 425–434.

    Article  CAS  PubMed  Google Scholar 

  3. Dustin M.L., Rothlein R., Bhan A.K., Dinarello C.A., Springer T.A. Induction by IL 1 and interferon-ψ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 1986, 137: 245–254.

    CAS  PubMed  Google Scholar 

  4. Weetman A.P., Cohen S., Makgoba M.W., Borysiewicz L.K. Expression of an Intercellular Adhesion Molecule, ICAM-1, by human thyroid cells. J. Endocrinol. 1989, 122: 185–191.

    Article  CAS  PubMed  Google Scholar 

  5. Seth R., Raymond F.D., Makgoba M.W. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991, 1: 83–84.

    Article  Google Scholar 

  6. Rothlein R., Mainolfi E.A., Czajkowski M., Marlin S.D. A form of circulating ICAM-1 in human serum. J. Immunol. 1991, 147: 3788–3793.

    CAS  PubMed  Google Scholar 

  7. Budnik A., Grewe M., Gyufko K., Krutmann J. Analysis of the production of soluble ICAM-1 molecules by human cells. Exp. Hematol. 1996, 24: 352–359.

    CAS  PubMed  Google Scholar 

  8. Gearing A.J.H., Newman W. Circulating adhesion molecules in disease. Immunol. Today 1993, 14: 506–512.

    Article  CAS  PubMed  Google Scholar 

  9. Heufelder A.E., Bahn R.S. Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves’ ophtalmopathy and thyroid diseases. Clin. Exp. Immunol. 1993, 92: 296–302.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Balasz C., Kiss E. Soluble Intercellular Adhesion Molecule-1 (sICAM-1) in Graves’ disease. Acta Microbiol. Immunol. Hungarica 1994, 41: 451–456.

    Google Scholar 

  11. Wenisch C., Myskiw D., Parschalk B., Hartmann T., Dam K., Graninger W. Soluble endothelium-associated adhesion molecules in patients with Graves’ disease. Clin. Exp. Immunol. 1994, 98: 240.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Wenisch C., Myskiw D., Gessl A., Graninger W. Circulating selectins, Intercellular Adhesion Molecule-1, and Vascular Cell Adhesion Molecule-1 in Graves’ disease. J. Clin. Endocrinol. Metab. 1995, 80: 2122–2126.

    CAS  PubMed  Google Scholar 

  13. De Bellis A., Bizzarro A., Gattoni A., Romano C., Di Martino S., Sinisi A.A., Abbadessa S., Bellastella A. Behavior of soluble Intercellular Adhesion Molecule-1 and Endothelial-Leukocyte Adhesion Molecule-1 concentrations in patients with Graves’ disease with or without ophthalmopathy and patients with toxic adenoma. J. Clin. Endocrinol. Metab. 1995, 80: 2118–2121.

    PubMed  Google Scholar 

  14. Fukazawa H., Yoshida K., Kaise N., Kiso Y., Sayama N., Mori K., Kikuchi K., Aizawa Y., Rikimaur A., Abe K. Intercellular Adhesion Molecule-1 (ICAM-1) in the sera of patients with Graves’ disease: correlation with disease activity and treatment status. Thyroid 1995, 5: 373–377.

    Article  CAS  PubMed  Google Scholar 

  15. Massart C., Hody B., Mouchel L., Edan G., Nicol M. Assays for thyrotropin-Receptor Binding and Thyroid-Stimulating Antibodies in sera from patients with Graves’ disease. Clin. Chem. 1986, 32: 1332–1335.

    CAS  PubMed  Google Scholar 

  16. Pigott R., Dillon L.P., Hemingway I.H., Gearing A.J.H. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem. Biophys. Res. Commun. 1992, 187: 584–589.

    Article  CAS  PubMed  Google Scholar 

  17. Massart C., Sonnet E., Gibassier J., Genetet N., Leclech G., Maugendre D. Expression of membrane and soluble InterCellular Adhesion Molecule-1 in Graves’ disease. J. Mol. Endocrinol. 1997, 19: 191–201.

    Article  CAS  PubMed  Google Scholar 

  18. Meyer D.M., Dustin M.L., Carron C.P. Characterization of Intercellular Adhesion Molecule-1 ectodomain (sICAM-1) as an inhibitor of Lymphocyte Function-Associated Molecule-1 interaction with ICAM-1. J. Immunol. 1995, 155: 3578–3584.

    CAS  PubMed  Google Scholar 

  19. Massart C., Sonnet E., Gibassier J., Maugendre D., Genetet B. Clinical validity of intercellular adhesion molecule-1 (ICAM-1) and TSH receptor antibodies in sera from patients with Graves’ disease. Clin. Chim. Acta 1997, 265: 157–168.

    Article  CAS  PubMed  Google Scholar 

  20. Heufelder A.E. Pathogenesis of Graves’ ophthalmopathy: recent controversies and progress. Eur. J. Endocrinol. 1995, 132: 532–541.

    Article  CAS  PubMed  Google Scholar 

  21. De Bellis A., Di Martino S., Fiordelisi F., Muccitelli V.I., Sinisi A.A., Abbate G.F., Gargano D., Bellastella A., Bizzarro A. Soluble Intercellular Adhesion Molecule-1 (sICAM-1) concentrations in Graves’ disease patients followed for development of ophthalmopathy. J. Clin. Endocrinol. Metab. 1998, 83: 1222–1225.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’Endocrinologie, Centre Hospitalier Universitaire de Rennes, Hôpital Sud 16, Boulevard de Bulgarie, 35056, Rennes Cedex 2, France

    E. Sonnet, H. Allannic &  D. Maugendre

  2. Laboratoire de Génétique Moléculaire et Hormonologie, Centre Hospitalier Universitaire de Rennes, France

    C. Massart & J. Gibassier

  3. Groupement Universitaire de Recherche en Immunologie Fondamentale et Appliquée (GURIFA), Centre Hospitalier Universitaire de Rennes, France

    C. Massart, H. Allannic &  D. Maugendre

Authors
  1. E. Sonnet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Massart
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Gibassier
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Allannic
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Maugendre
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sonnet, E., Massart, C., Gibassier, J. et al. Longitudinal study of soluble intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves’ disease. J Endocrinol Invest 22, 430–435 (1999). https://doi.org/10.1007/BF03343586

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343586

Key-words

Search

Navigation